Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders

Yuksek Ihtisas Hospital

Status and phase: Completed; Phase 3; Phase 2

Conditions: Cardiomyopathy

Treatments: Device: Cardiac Resynchronization Therapy Device

Study type: Interventional

Funder types: Other

Identifiers

NCT02247427

TYIH-132

Details and patient eligibility

About

The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.

Enrollment: 19 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• super response to Cardiac Resynchronization Therapy
• near normal Left ventricular ejection fraction
• >99% pacing

Exclusion criteria

• <99% pacing
• atrial fibrillation
• ischemic cardiomyopathy

Trial design

19 participants in 2 patient groups

Off-pace group

Experimental group

Description:

Deactivated device group

Treatment:

Device: Cardiac Resynchronization Therapy Device

On-Pace group

No Intervention group

Description:

Ongoing device activity group